Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our best in class AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients. Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by linked evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.

Every building material, narrowed down to a few recommendations. ACELAB is a free, non-sponsored, visual search engine for building products.

Adaptilens is the only IOL that imitates the human eye’s natural lens. We are a team of ophthalmologists, cataract specialists, scientists, and engineers with a singular focus on improving the vision and quality of life of cataract patients. We are developing an accommodating IOL with novel polymers to give patients the ability to focus not just on a single distance but on objects near, far, and in between—without the help of glasses or contact lenses. To stay updated as our life-changing lens technology develops, follow us here or sign up for updates here: https://adaptilens.com/contact/

Addis Energy is scaling a new ammonia production pathway that revolutionizes the century-old chemical production process. By targeting iron-rich resources in the subsurface, Addis is forging a new method for chemical synthesis: injecting engineered fluids that harness the chemical and thermal potential of the Earth to produce clean ammonia. This transforms ammonia synthesis into a net energy positive process without any CO2 emissions and enables producing ammonia cheaper than traditional methods.

Algorand is positioned to address the blockchain’s scaling challenges through rapid and efficient user consensus, enabling even the smallest transactions, regardless of transaction volume or number of users.

Building AI software development agents for everyone, in the open.

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits to reach previously undruggable patient populations. The current paradigm in genetic medicine relies on developing independent therapies for each separate mutation in the patient population. Founded by pioneers in the CRISPR field from leading institutions for gene editing research, the company is developing a first-of-its-kind RNA writing platform capable of editing thousands of diverse mutations across patients with a single product.

Amplifyer Bio, Inc. is an exciting new startup developing technology of transformative potential for the liquid biopsy field and the product of a collaboration between the labs of Dr. Sangeeta Bhatia, Dr. Chris Love, and Dr. Viktor Adalsteinsson at MIT and the Broad Institute. The work has been published in Science and has been presented at leading conferences both in the US and internationally. The company is focused on the development of novel priming agents that, in combination with current liquid biopsy diagnostics, will improve test performance. Amplifyer’s first program will be focused on increasing cfDNA in blood for cancer diagnostics. This will provide both physicians and patients higher quantity and quality of genomic information related to their cancer, with the aim of improving clinical outcomes.

Our mission is to translate novel and unique insights regarding the intersection of cardiac biology and the immune system. We are developing new therapies that address core problems in abnormal heart rhythms. We believe that our technology and approach can address significant medical needs in patients with Arrhythmogenic Right Ventricular Cardiomyopathy, Cardiac Sarcoid and Post-Covid arrhythmias.

Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.

Ayo Ayo is an electronics design consulting firm specializing in mixed signal printed circuit board design. We provide expert consulting services to bring your electronics projects to life.

Bigup is an interactive sports entertainment platform where people come together to watch and chat about football (soccer) with their online communities. Bigup's proprietary technology allows streamers to offer their communities a broadcasting experience on par with television networks, without the need for a production team or expensive hardware equipment.